Results 281 to 290 of about 3,645,426 (307)
Some of the next articles are maybe not open access.
Immunotherapy for colorectal cancer
Current Oncology Reports, 1999The outlook for patients with colorectal cancer has improved considerably in the past decade with the development and widespread use of 5-fluorouracil (5-FU)-based adjuvant chemotherapy for patients with stage III colon cancer or stages II or III rectal cancer; the introduction of effective new agents such as irinotecan and oxaliplatin; and the ...
C A, Maxwell-Armstrong +2 more
openaire +4 more sources
Complement in Cancer and Cancer Immunotherapy
Archivum Immunologiae et Therapiae Experimentalis, 2011Recently, there has been an increase of interest in the use of biological or immune-based therapies for patients with malignancies. This has been informed by the deeper understanding of the crosstalk between the host immune system and malignant tumours, as well as the potential advantages of immunotherapy-high specificity and less toxicity compared to ...
Martin, Kolev +2 more
openaire +4 more sources
1989
When, in the 1960s Burnet’s immunosurveillance hypotheses became common knowledge among clinicians, many of them took it for granted that human tumors carried tumor antigens which allowed the host, theoretically, to recognize and reject his or her own cancer cells.
openaire +2 more sources
When, in the 1960s Burnet’s immunosurveillance hypotheses became common knowledge among clinicians, many of them took it for granted that human tumors carried tumor antigens which allowed the host, theoretically, to recognize and reject his or her own cancer cells.
openaire +2 more sources
Immunotherapy in Prostate Cancer
Current Urology Reports, 2015Immunotherapy for the treatment of malignant neoplasms has made significant progress over the last 20 years. Multiple molecular targets and clinical agents have been developed recently, particularly in the field of metastatic adenocarcinoma of the prostate. Sipuleucel-T is currently the only FDA approved immunotherapy for prostate cancer.
Ilya, Sobol +4 more
openaire +2 more sources
Neoantigens in cancer immunotherapy
Science, 2015The clinical relevance of T cells in the control of a diverse set of human cancers is now beyond doubt. However, the nature of the antigens that allow the immune system to distinguish cancer cells from noncancer cells has long remained obscure. Recent technological innovations have made it possible to dissect the immune response to patient-specific ...
Ton N, Schumacher, Robert D, Schreiber
openaire +2 more sources
Immunotherapy in colorectal cancer
Scandinavian Journal of Gastroenterology, 2009Udgivelsesdato ...
Burgdorf, Stefan K +2 more
openaire +3 more sources
Immunotherapy of breast cancer
Expert Opinion on Biological Therapy, 2012Immunotherapy of breast cancer has been shown to prevent recurrence, improve survival and eliminate breast cancer in humans.The reason for this review is to present the current information and the prospects for the future of immunotherapy of breast cancer in humans to include tumor antigens for vaccines and targets for monoclonal antibodies and ...
openaire +2 more sources
Cancer Immunotherapy—An Overview
Immunotherapy has had a profound impact on how we treat cancer. Immunotherapy takes advantage of the body's immune system to combat the disease and is considered as one of the pillars of cancer care together with chemotherapy, radiation therapy, and surgery.Prakash, Kulkarni +4 more
openaire +2 more sources